Your browser doesn't support javascript.
loading
Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
Abergel, A; Hezode, C; Leroy, V; Barange, K; Bronowicki, J P; Tran, A; Alric, L; Castera, L; Bernard, P-H; Henquell, C; Lafeuille, H; Ughetto, S; Darcha, C; Chevallier, M; Martineau, N; Dubost, S; Randl, K; Dhumeaux, D; Bommelaer, G; Bonny, C.
Affiliation
  • Abergel A; Service d'Hépato-Gastroentérologie, Hôtel-Dieu, Clermont-Ferrand, France. aabergel@chu-clermontferrand.fr
J Viral Hepat ; 13(12): 811-20, 2006 Dec.
Article in En | MEDLINE | ID: mdl-17109680
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Interferon-alpha / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2006 Document type: Article Affiliation country: France Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Interferon-alpha / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2006 Document type: Article Affiliation country: France Country of publication: United kingdom